What I was thinking was more along the lines of detailing current C-125, Vermillion, the one that we discussed a couple weeks ago and this most recent one. Detail the use, the process, the targets, etc. Even go into detail on the numbers used by Vermillion and the other one to get regulatory approval, etc. The press is lazy and so is much of Wall Street. ARYC cleary is. So spend some time and put this together and publicize it.
Heck, if I were them, I'd consider putting it together and emailing it to every reporter that covered the other story. I saw the MD Anderson story on two local channels.
AI
Market Data 
Markets 
